BCRX - BioCryst surges 18% on quarterly earnings adjusted guidance outlook
2024-05-06 10:36:37 ET
More on BioCryst Pharmaceuticals
- BioCryst Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation
- BioCryst's Revenue Gains Offset By Rising Expenses: A Closer Look
- BioCryst Pharmaceuticals, Inc. (BCRX) Q4 2023 Earnings Call Transcript
- BioCryst Pharmaceuticals beats top-line and bottom-line estimates; updates FY24 outlook
- BioCryst Pharmaceuticals Q1 2024 Earnings Preview